The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 9 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,020 followers.

RT @IenI_UMCUtrecht: Cancer researchers from @CTI_UMCUtrecht (lead by @JKuball) explored better designs for g9d2TCR anti-CD3 bispecific mol…

25 Jan 2023

Reply Repost Favourite

Cancer researchers from @CTI_UMCUtrecht (lead by @JKuball) explored better designs for g9d2TCR anti-CD3 bispecific molecules (GABs). Current bottleneck is the engineering of protein production, which must be improved before testing of these GABs can start

23 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.